Stockreport

Relmada prices $100M equity offering [Seeking Alpha]

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
PDF Relmada prices $100M equity offering Relmada Therapeutics (NASDAQ: RLMD priced Underwriters' over-allotment is an additional 500,000 shares. The closing date is December [Read more]